Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis

被引：112

作者：

Parks, Tom ^{[1
]}

Wilson, Clare ^{[2
]}

Curtis, Nigel ^{[3
]}

Norrby-Teglund, Anna ^{[4
]}

Sriskandan, Shiranee ^{[2
]}

机构：

[1] London Sch Hyg & Trop Med, London, England

[2] Imperial Coll London, London, England

[3] Royal Childrens Hosp, Melbourne, Vic, Australia

[4] Karolinska Inst, Stockholm, Sweden

来源：

CLINICAL INFECTIOUS DISEASES | 2018年 / 67卷 / 09期

基金：

英国医学研究理事会;

关键词：

Group A streptococcus; Streptococcus pyogenes; intravenous immunoglobulin; streptococcal toxic shock syndrome; necrotising fasciitis; THERAPY; INFECTIONS; DISEASE;

D O I：

10.1093/cid/ciy401

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We evaluated the effect of intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% with remarkable consistency across the single randomized and four nonrandomized studies.

引用

页码：1434 / 1436

页数：3

共 12 条

[1] Toxic shock syndrome surveillance in UK children
Adalat, S.
Dawson, T.
Hackett, S. J.
Clark, J. E.
[J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (12) : 1078 - 1082
[2] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION
BREIMAN, RF
DAVIS, JP
FACKLAM, RR
GRAY, BM
HOGE, CW
KAPLAN, EL
MORTIMER, EA
SCHLIEVERT, PM
SCHWARTZ, B
STEVENS, DL
TODD, JK
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03): : 390 - 391
[3] Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections
Carapetis, Jonathan R.
Jacoby, Peter
Carville, Kylie
Ang, Seong-Jin Joel
Curtis, Nigel
Andrews, Ross
[J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (03) : 358 - 365
[4] Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:: A European randomized, double-blind, placebo-controlled trial
Darenberg, J
Ihendyane, N
Sjölin, J
Aufwerber, E
Haidl, S
Follin, P
Andersson, J
Norrby-Teglund, A
[J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 333 - 340
[5] Synergy, Salary, and Satisfaction: Benefits of Training in Critical Care Medicine and Infectious Diseases Gleaned From a National Pilot Survey of Dually Trained Physicians
Kadri, Sameer S.
Rhee, Chanu
Magda, Gabriela
Strich, Jeffrey R.
Cai, Rongman
Sun, Junfeng
Decker, Brooke K.
O'Grady, Naomi P.
[J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (07) : 868 - 875
[6] Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - A comparative observational study
Kaul, R
McGeer, A
Norrby-Teglund, A
Kotb, M
Schwartz, B
O'Rourke, K
Talbot, J
Low, DE
[J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) : 800 - 807
[7] Predictors of Death after Severe Streptococcus pyogenes Infection
Lamagni, Theresa L.
Neal, Shona
Keshishian, Catherine
Powell, David
Potz, Nicola
Pebody, Richard
George, Robert
Duckworth, Georgia
Vuopio-Varkila, Jaana
Efstratiou, Androulla
[J]. EMERGING INFECTIOUS DISEASES, 2009, 15 (08) : 1304 - 1307
[8] Clinical Efficacy of Polyspecific Intravenous Immunoglobulin Therapy in Patients With Streptococcal Toxic Shock Syndrome: A Comparative Observational Study
Linner, Anna
Darenberg, Jessica
Sjolin, Jan
Henriques-Normark, Birgitta
Norrby-Teglund, Anna
[J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (06) : 851 - 857
[9] Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU
Mehta, Sangeeta
McGeer, Allison
Low, Donald E.
Hallett, David
Bowman, Dennis J.
Grossman, Stacey L.
Stewart, Thonas E.
[J]. CHEST, 2006, 130 (06) : 1679 - 1686
[10] Intravenous Immunoglobulin in Children with Streptococcal Toxic Shock Syndrome
Shah, Samir S.
Hall, Matthew
Srivastava, Raj
Subramony, Anupama
Levin, James E.
[J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (09) : 1369 - 1376

← 1 2 →